Surgical Mask Market

Surgical Mask Market Segmentation by Product (Anti-Fog, Basic, Fluid/Splash Resistant Surgical Masks, and N95 Mask); by Material (Cotton, Polypropylene, Cellulose & Paper, Polyester, Polyethylene, Polystyrene, Biodegradable Polymers, Biomass Material, Polycarbonate, and Others); by Securing Method (Tie-Band, and Ear-Loop); by End-Users – Global Demand Analysis & Opportunity Outlook 2019-2028

Buy Now
Report ID: 3551 | Published On: Apr 11, 2022
  1. Introduction
    • Market Definition
    • Market Segmentation
    • Product Overview
  2. Assumptions and Acronyms
  3. Research Methodology
  4. Research Process
    • Primary Research
    • Manufacturers
    • Distributors
    • End Users
    • Secondary Research
    • Market Size Estimation
  5. Executive Summary - Global Advanced Therapy Medicinal Products Market
  6. Analysis of Market Dynamics
  7. Drivers
  8. Trends
  9. Key Market Opportunities for Business Growth
  10. Major Roadblocks for the Market Growth
  11. Regulatory & Standard Landscape
  12. Value Chain Analysis
  13. Potential ATMP Treatment Analysis
  14. Pricing Analysis of Global Advanced Therapy Medicinal Products Market
  15. Use Case Analysis
  16. Pipeline Analysis
  17. Analysis on the Manufacturing Process
  18. Analysis of COVID-19 Impact on the Global Advanced Therapy Medicinal Products Market
  19. Analysis of End-User Market Share of Global Advanced Therapy Medicinal Products
  20. Competitive Positioning
  21. Competitive Landscape
  22. Market Share Analysis of Major Players (%), 2021
  23. Competitive Benchmarking
  24. Novartis AG.
  25. Takeda Pharmaceutical Company Limited
  26. Gilead Sciences, Inc.
  27. Bluebird Bio, Inc
  28. BioMarin Pharmaceutical Inc
  29. Vericel Corporation
  30. Mallinckrodt Pharmaceuticals
  31. UniQure N.V.
  32. JCR Pharmaceuticals Co., Ltd.
  33. Spark Therapeutics, Inc. (Parent Company: Roche)
  34. Kolon TissueGene, Inc.
  35. Global Advanced Therapy Medicinal Products Market Outlook
  36. By Value (USD million)
  37. By Product
  38. CAR-T Therapy, 2021-2031F (USD million)
  39. Gene Therapy, 2021-2031F (USD million)
  40. Cell Therapy, 2021-2031F (USD million)
  41. Tissue Engineered Product, 2021-2031F (USD million)
  42. By Disease
  43. Oncology, 2021-2031F (USD million)
  44. Genetic Disorders, 2021-2031F (USD million)
  45. CNS, 2021-2031F (USD million)
  46. Dermatology, 2021-2031F (USD million)
  47. Others, 2021-2031F (USD million)
  48. By End-User
  49. Hospitals & Clinics, 2021-2031F (USD million)
  50. Research & Academic Institutes, 2021-2031F (USD million)
  51. Global Advanced Therapy Medicinal Products Market by Region
  52. North America, 2021-2031F (USD million)
  53. Europe, 2021-2031F (USD million)
  54. Asia-Pacific, 2021-2031F (USD million)
  55. Latin America, 2021-2031F (USD million)
  56. Middle East & Africa, 2021-2031F (USD million)
  57. North America Advanced Therapy Medicinal Products Market Outlook
  58. By Value (USD million)
  59. By Product
  60. CAR-T Therapy, 2021-2031F (USD million
  61. Gene Therapy, 2021-2031F (USD million)
  62. Cell Therapy, 2021-2031F (USD million)
  63. Tissue Engineered Product, 2021-2031F (USD million)
  64. By Disease
  65. Oncology, 2021-2031F (USD million)
  66. Genetic Disorders, 2021-2031F (USD million)
  67. CNS, 2021-2031F (USD million)
  68. Dermatology, 2021-2031F (USD million)
  69. Others, 2021-2031F (USD million)
  70. By End-User
  71. Hospitals & Clinics, 2021-2031F (USD million)
  72. Research & Academic Institutes, 2021-2031F (USD million)
  73. By Country
  74. US, 2021-2031F (USD million)
  75. Canada, 2021-2031F (USD million)
  76. Europe Advanced Therapy Medicinal Products Market Outlook
  77. By Product
  78. By Disease
  79. By End User
  80. By Country
  81. UK, 2021-2031F (USD Million)
  82. Germany, 2021-2031F (USD Million)
  83. France, 2021-2031F (USD Million)
  84. Italy, 2021-2031F (USD Million)
  85. Spain, 2021-2031F (USD Million)
  86. Russia, 2021-2031F (USD Million)
  87. Netherlands, 2021-2031F (USD Million)
  88. Rest of Europe, 2021-2031F (USD Million)
  89. Asia Pacific Advanced Therapy Medicinal Products Market Outlook
  90. By Product
  91. By Disease
  92. By End User
  93. By Country
  94. China, 2021-2031F (USD Million)
  95. India, 2021-2031F (USD Million)
  96. Japan, 2021-2031F (USD Million)
  97. South Korea, 2021-2031F (USD Million)
  98. Singapore, 2021-2031F (USD Million)
  99. Australia, 2021-2031F (USD Million)
  100. Rest of Asia-Pacific, 2021-2031F (USD Million)
  101. Latin America Advanced Therapy Medicinal Products Market Outlook
  102. By Product
  103. By Disease
  104. By End User
  105. By Country
  106. Brazil, 2021-2031F (USD Million)
  107. Argentina, 2021-2031F (USD Million)
  108. Mexico, 2021-2031F (USD Million)
  109. Rest of Latin America, 2021-2031F (USD Million)
  110. Middle East & Africa Advanced Therapy Medicinal Products Market Outlook
  111. By Product
  112. By Disease
  113. By End User
  114. By Country
  115. GCC, 2021-2031F (USD Million)
  116. Israel, 2021-2031F (USD Million)
  117. South Africa, 2021-2031F (USD Million)
  118. Rest of Middle East & Africa, 2021-2031F (USD Million)

Preview Analysis

Request Insights
Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022. Purchasing power in the country is expected to fell nearly by 2.5%.
On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.


In The News

  • December 1st, 2020: The World Health Organization (WHO), released an interim guidance regarding the use of mask in the context of COVID-19. The key points included multiple advisories on the use of masks to control the spread of SARS-CoV-2 virus that causes COVID-19, especially to those who were awaiting viral laboratory test results or were suspected or confirmed of having the disease. The report also shared guidelines on the use of mask in health care settings, community settings, use of masks in children, along with the guidance for the manufacturing of non-medical (fabric) masks.

  • July 23rd, 2021: The WHO’s Regional Office for Europe and ECDC announced that between June 28th and July 11th, 2021, the SARS-CoV-2 Delta variant was dominant in 19 countries of the 28 countries in the Europe region. Moreover, of the surveillance data collected from these 19 countries, 68.3% of the share of these data reported to be the Delta variant, overtaking the previously dominant Alpha variant with 22.3%. Moreover, an advisory to follow the 3Ws, i.e., wearing a mask, washing hands, and watching one’s distance, was also floated by the officials.

  • May 7th, 2020: 3M Company announced that it had received two contracts from the U.S. Department of Defense for expanding its production of N95 respirators to more than 95 Million per month by October 2020. Back in the month of January, the company had already ramped up production of its respirators around the globe with an output capacity of 1.1 Billion per year.


Global Surgical Mask Market Highlights Over 2019 - 2028

The global surgical mask market is estimated to garner a revenue of USD 13145.08 Million by the end of 2028, by growing at a CAGR of (-)18.1% over the forecast period, i.e., 2020 – 2028. Moreover, in the year 2019, the market registered a revenue of USD 4658.46 Million. The growth of the market can be attributed to growing concern for the rising coronavirus cases worldwide, and therefore the need amongst individuals to wear a mask. Additionally, increasing number of surgeries performed globally, and the rising awareness for personal safety from airborne infections, are also expected to contribute to the market growth in the coming years. Besides this, the market is expected to generate a revenue of USD 53292.80 Million by the end of 2021.

Surgical Mask Market Graph

Get more information on this reportDownload Sample PDF

One of the major factors that drove the demand for surgical masks in the year 2020, and is continuing till today, is the rising cases of coronavirus. According to the statistics by the WHO, as of September 16th, 2021, a total of 226236577 confirmed cases of COVID-19 around the world had been registered. This was an increase from 45 confirmed cases as of January 6th, 2020. Moreover, 4654548 deaths were reported till the same date. 

Cumulative Coronavirus Graph

Moreover, growing need for improving healthcare infrastructure, followed by the rising healthcare expenditure worldwide is also expected to contribute to the market growth. Besides this, the growing incidences of influenza and other infectious diseases, such as TB, diarrheal disease, and others, is also projected to drive the market growth.


Global Surgical Mask Market Regional Synopsis

Regionally, the global surgical mask market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America region is expected to garner the largest revenue of USD 4443.04 Million by the end of 2028, backed by the robust healthcare infrastructure of the region, and for the favorable initiatives of the government of nations such as the United States to upgrade the medical infrastructure. The market in the region is further segmented by country into the United States and Canada, out of which, the market in the United States registered the largest market revenue in the year 2019, and is further expected to hold the highest market revenue during the forecast period. One of the major factors expected to drive the demand for surgical masks in the country is for the rising need amongst individuals to wear double masks. The United States Centers for Disease Control and Prevention (CDC), in its Morbidity and Mortality Weekly Report (MMWR) dated February 19th, 2021, in one of its experiments examined the best effective way of using masks so as to limit the spread of the coronavirus. Based on the results, the experimental group proposed double masking as another means to maximize the filtration properties as combining two different mask types could reduce a wearer’s exposure to the virus by over 90%.

The study further incorporates Y-O-Y Growth, market opportunities, demand & supply and forecast future opportunity in North America (United States, Canada, Mexico), South America, Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).


Growth Drivers and Challenges Impacting the Growth of the Global Surgical Mask Market

Growth Drivers

  • Growing Prevalence of Airborne Diseases
  • Rising Number of Surgeries Worldwide

Challenges

  • Claims Regarding Lack of Effectiveness and Airflow of Surgical Masks


Surgical Mask Market Graph
Get more information on this report: Request Sample PDF

Global Surgical Mask Market Segmentation Synopsis

The global surgical mask market is segmented by product into anti-fog surgical mask, basic surgical mask, fluid/splash resistant surgical mask, and N95 mask. Out of these segments, the basic surgical mask segment is expected to register the largest market revenue of USD 6162.59 Million by the end of 2028, up from a revenue of USD 2216.95 Million in the year 2019. Based on material, the market is segmented into cotton, polypropylene, cellulose & paper, polyester, polyethylene, polystyrene, biodegradable polymers, biomass material, polycarbonate, and others. Out of these, the polypropylene segment registered the largest market revenue of USD 1129.21 Million in the year 2019, and is further expected to touch USD 3013.83 Million by the end of 2028. On the basis of securing method, the market is segmented into tie-band, and ear-loop, out of which, the ear-loop segment is expected to garner the largest market revenue by the end of 2028 and also hold the highest market share throughout the forecast period. The market is further segmented on the basis of end-users into hospital, clinics, ambulatory surgical centers, and others. Amongst these segments, the hospital segment registered the largest revenue of USD 1964.01 Million in the year 2019, and is further projected to hold the largest market revenue by the end of 2030. Further, on the basis of distribution channel, the market is segmented into online and offline, out of which, the offline segment is projected to hold the highest market share throughout the forecast period.


Key Companies Dominating the Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global surgical mask market that are included in our report are 3M Company, Medicare Hygiene Limited, Premium Health Care Disposables Private Limited, Mediblue Healthcare Private Limited, Moldex-Metric, Inc., Kowa Company, Ltd., DACH Schutzbekleidung GmbH & Co. KG, Prestige Ameritech, and others.


Cumulative Coronavirus Graph

Key Questions Answered in the Report

1) What are the major factors driving the growth of the surgical mask market?

Ans: The growing cases of the coronavirus pandemic and the rising need amongst individuals to prevent themselves from airborne diseases are some of the major factors anticipated to drive the market growth.

2) What would be the CAGR of surgical mask market over the forecast period?

Ans: The market is anticipated to attain a CAGR of (-)18.1% over the forecast period, i.e., 2020 – 2028.

3) What are the challenges affecting the surgical mask market growth?

Ans: The claims regarding lack of effectiveness and airflow of surgical masks is one of the major factors estimated to hamper the market growth.

4) Which region will provide more business opportunities for growth of surgical mask market in future?

Ans: The market in North America is expected to garner the largest revenue of USD 4443.04 Million by the end of 2028, and display significant business opportunities.

5) Who are the major players dominating the surgical mask market?

Ans: The major players in the market are 3M Company, Medicare Hygiene Limited, Premium Health Care Disposables Private Limited, Mediblue Healthcare Private Limited, and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the surgical mask market?

Ans: The market is segmented by product, material, securing method, end-users, distribution channel, and by region.

8) Which segment captures the largest market size in product segment in the surgical mask market?

Ans: The basic surgical mask segment is expected to register the largest market revenue of USD 6162.59 Million by the end of 2028 and display significant growth opportunities.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Submit RFP    Buy Now Download Research Report Sample